Stocks US appeals court reinstates Regeneron’s antitrust case against Novartis From ReutersMarch 18, 2024 NEW YORK (Reuters) – A U.S. appeals court on Monday revived Regeneron (NASDAQ:) Pharmaceuticals’ antitrust…
Finance Novartis shareholder vote ‘contradicts the spirit of the law’ – EthosFebruary 16, 2024 According to proxy voting specialist Ethos, Novartis is failing its shareholders by not fully complying…
